Prediction of Delayed Cognitive Impairment in Cardiac Arrest Survivors With Good Neurological Outcomes
Launched by CHUNGNAM NATIONAL UNIVERSITY HOSPITAL · Apr 24, 2023
Trial Information
Current as of July 21, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
1. For study subjects who survived after out-of-hospital cardiac arrest, prognosis was evaluated using Cerebral Performance Category (CPC) scores on days 10-14 after return of spontaneous circulation (ROSC). A CPC score of 1-2 indicates a good neurological prognosis, while a score of 3-5 indicates a poor neurological prognosis. Only subjects with CPC scores of 1-2 were included in this study.
2. Blood samples were collected through venous puncture at days 10-14, 3 months, and 6 months after ROSC, and the obtained blood was drawn into an serum separating tube (SST) bottle without anticoagula...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients who visited the hospital emergency room due to cardiac arrest within 60 months after Institutional Review Board (IRB) approval
- • Patients with Glasgow Coma Scale (GCS) less than 8 points after spontaneous circulation recovery
- • Patients who are 18 years old or older
- • Patients who underwent targeted temperature management (TTM)
- • Patients who showed good neurological outcomes with CPC 1-2 points after evaluating the prognosis on days 10-14 after ROSC
- Exclusion Criteria:
- • Under 18 years of age
- • cardiac arrest cause is trauma
- • Patients who have not undergone targeted temperature management
- • Patients treated with extracorporeal membrane oxygenation (ECMO)
- • Patients who were not able to undergo SNSB testing
- • Patients who could not be followed up until 6 months after ROSC
About Chungnam National University Hospital
Chungnam National University Hospital (CNUH) is a leading medical institution in South Korea, dedicated to advancing healthcare through innovative clinical research and trials. As a prominent teaching hospital affiliated with Chungnam National University, CNUH combines cutting-edge medical technologies with a commitment to patient-centered care. The hospital fosters a collaborative environment for researchers and clinicians, aiming to enhance medical knowledge and improve treatment outcomes across various specialties. With a strong emphasis on ethical practices and patient safety, CNUH plays a pivotal role in the development of new therapies and interventions, contributing to the global advancement of medical science.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Daejeon, Seo Gu, Korea, Republic Of
Patients applied
Trial Officials
Jung Soo Park, MD.Phd
Study Chair
(35015) Chungnam National University Hospital, 282 Munhwa-ro, Jung-gu, Daejeon
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported